Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort.

Shashwath A Meda | Balaji Narayanan | Jingyu Liu | Nora I Perrone-Bizzozero | Michael C Stevens | Vince D Calhoun | David C Glahn | Li Shen | Shannon L Risacher | Andrew J Saykin | Godfrey D Pearlson
NeuroImage | 2012

The underlying genetic etiology of late onset Alzheimer's disease (LOAD) remains largely unknown, likely due to its polygenic architecture and a lack of sophisticated analytic methods to evaluate complex genotype-phenotype models. The aim of the current study was to overcome these limitations in a bi-multivariate fashion by linking intermediate magnetic resonance imaging (MRI) phenotypes with a genome-wide sample of common single nucleotide polymorphism (SNP) variants. We compared associations between 94 different brain regions of interest derived from structural MRI scans and 533,872 genome-wide SNPs using a novel multivariate statistical procedure, parallel-independent component analysis, in a large, national multi-center subject cohort. The study included 209 elderly healthy controls, 367 subjects with amnestic mild cognitive impairment and 181 with mild, early-stage LOAD, all of them Caucasian adults, from the Alzheimer's Disease Neuroimaging Initiative cohort. Imaging was performed on comparable 1.5 T scanners at over 50 sites in the USA/Canada. Four primary "genetic components" were associated significantly with a single structural network including all regions involved neuropathologically in LOAD. Pathway analysis suggested that each component included several genes already known to contribute to LOAD risk (e.g. APOE4) or involved in pathologic processes contributing to the disorder, including inflammation, diabetes, obesity and cardiovascular disease. In addition significant novel genes identified included ZNF673, VPS13, SLC9A7, ATP5G2 and SHROOM2. Unlike conventional analyses, this multivariate approach identified distinct groups of genes that are plausibly linked in physiologic pathways, perhaps epistatically. Further, the study exemplifies the value of this novel approach to explore large-scale data sets involving high-dimensional gene and endophenotype data.

Pubmed ID: 22245343

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: P30 AG010133
  • Agency: NIA NIH HHS, United States
    Id: U01 AG032984
  • Agency: CIHR, Canada
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-03
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005846-05A1
  • Agency: NIA NIH HHS, United States
    Id: P30 AG10133-18S1
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-08
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005846-04
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-06
  • Agency: NCI NIH HHS, United States
    Id: R01 CA101318
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-05
  • Agency: NCI NIH HHS, United States
    Id: R01 CA101318-03
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005846-06
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB020407
  • Agency: NIA NIH HHS, United States
    Id: K01 AG030514
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-10
  • Agency: NCI NIH HHS, United States
    Id: R01 CA101318-02
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005846-02
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-04
  • Agency: PHS HHS, United States
    Id: R0IEB005846
  • Agency: NIA NIH HHS, United States
    Id: U01 AG024904
  • Agency: NIA NIH HHS, United States
    Id: U19 AG010483
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005846
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005846-01
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-07
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB006841
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005846-03
  • Agency: NIA NIH HHS, United States
    Id: RC2 AG036535
  • Agency: NCI NIH HHS, United States
    Id: R01 CA101318-05
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005846-08
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-01
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-02
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005846-07
  • Agency: NIA NIH HHS, United States
    Id: R01 AG19771
  • Agency: NCI NIH HHS, United States
    Id: R01 CA101318-04
  • Agency: NIA NIH HHS, United States
    Id: R01 AG019771-09
  • Agency: NCI NIH HHS, United States
    Id: R01 CA101318-01A1
  • Agency: NIA NIH HHS, United States
    Id: P30 AG010129

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


DAVID (tool)

RRID:SCR_001881

Bioinformatics resource system including web server and web service for functional annotation and enrichment analyses of gene lists. Consists of comprehensive knowledgebase and set of functional analysis tools. Includes gene centered database integrating heterogeneous gene annotation resources to facilitate high throughput gene functional analysis.

View all literature mentions

FuncAssociate: The Gene Set Functionator (tool)

RRID:SCR_005768

A web-based tool that accepts as input a list of genes, and returns a list of GO attributes that are over- (or under-) represented among the genes in the input list. Only those over- (or under-) representations that are statistically significant, after correcting for multiple hypotheses testing, are reported. Currently 37 organisms are supported. In addition to the input list of genes, users may specify a) whether this list should be regarded as ordered or unordered; b) the universe of genes to be considered by FuncAssociate; c) whether to report over-, or under-represented attributes, or both; and d) the p-value cutoff. A new version of FuncAssociate supports a wider range of naming schemes for input genes, and uses more frequently updated GO associations. However, some features of the original version, such as sorting by LOD or the option to see the gene-attribute table, are not yet implemented. Platform: Online tool

View all literature mentions

Ingenuity Pathways Knowledge Base (tool)

RRID:SCR_008117

A horizontally and vertically structured database that pulls scientific and medical information and describes it consistently using the Ingenuity Ontology. The Knowledge Base pulls information from journals, public molecular content databases, and textbooks. Data is curated and and integrated into the Knowledge Base .

View all literature mentions

Ingenuity Pathway Analysis (tool)

RRID:SCR_008653

A web-based software application that enables users to analyze, integrate, and understand data derived from gene expression, microRNA, and SNP microarrays, metabolomics, proteomics, and RNA-Seq experiments, and small-scale experiments that generate gene and chemical lists. Users can search for targeted information on genes, proteins, chemicals, and drugs, and build interactive models of experimental systems. IPA allows exploration of molecular, chemical, gene, protein and miRNA interactions, creation of custom molecular pathways, and the ability to view and modify metabolic, signaling, and toxicological canonical pathways. In addition to the networks and pathways that can be created, IPA can provide multiple layering of additional information, such as drugs, disease genes, expression data, cellular functions and processes, or a researchers own genes or chemicals of interest.

View all literature mentions